Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Eyes on New Product Development.
Novack, Gary D.
J Ocul Pharmacol Ther ; 39(3): 189-190, 2023 04.
Article in English | MEDLINE | ID: covidwho-2301030

Subject(s)
Eye Diseases , Eye , Humans , Eye Diseases/drug therapy , Drug Approval , Administration, Ophthalmic , Drug Design
2.
Expedited regulatory product approval in the time of COVID-19.
Novack, Gary D.
Ocul Surf ; 26: 345-348, 2022 Oct.
Article in English | MEDLINE | ID: covidwho-1867439

Subject(s)
COVID-19 , Humans , United States/epidemiology , United States Food and Drug Administration , Drug Approval , Consumer Product Safety
3.
Eyes on New Product Development.
Novack, Gary D.
J Ocul Pharmacol Ther ; 37(7): 383-385, 2021 Sep.
Article in English | MEDLINE | ID: covidwho-1821676

Subject(s)
Drug Development , Eye Diseases/therapy , Genetic Therapy , Ophthalmic Solutions/therapeutic use , Administration, Ophthalmic , Drug Industry , Humans
4.
Eyes on New Product Development.
Novack, Gary D.
J Ocul Pharmacol Ther ; 37(6): 319-320, 2021.
Article in English | MEDLINE | ID: covidwho-1541499

Subject(s)
Drug Approval , Drug Design , Eye Diseases/drug therapy , Pharmaceutical Preparations/administration & dosage , Administration, Ophthalmic , Humans , United States
5.
Eyes on New Product Development.
Novack, Gary D.
J Ocul Pharmacol Ther ; 37(9): 493-494, 2021 11.
Article in English | MEDLINE | ID: covidwho-1517814

Subject(s)
Eye Diseases/drug therapy , Ophthalmology , Drug Approval/organization & administration , Drug Industry/organization & administration , Eye Diseases/physiopathology , Humans , United States , United States Food and Drug Administration/organization & administration
6.
Eyes on New Product Development: Regulations, Generics, and Disruptive Technologies.
Novack, Gary D.
J Ocul Pharmacol Ther ; 37(5): 249-250, 2021 Jun.
Article in English | MEDLINE | ID: covidwho-1458139

Subject(s)
Disruptive Technology/legislation & jurisprudence , Drug Delivery Systems/methods , Drug Development/methods , Drug Industry/legislation & jurisprudence , Biological Products/therapeutic use , Cell- and Tissue-Based Therapy/statistics & numerical data , Contact Lenses , Drug Approval/legislation & jurisprudence , Drugs, Generic , Equipment and Supplies/statistics & numerical data , Genetic Therapy/legislation & jurisprudence , Genetic Therapy/statistics & numerical data , Humans , Japan , United States , United States Food and Drug Administration
7.
Repurposing medications.
Novack, Gary D.
Ocul Surf ; 19: 336-340, 2021 01.
Article in English | MEDLINE | ID: covidwho-942139

Subject(s)
Drug Discovery
8.
Eyes on New Product Development.
Novack, Gary D.
J Ocul Pharmacol Ther ; 36(9): 659-660, 2020 11.
Article in English | MEDLINE | ID: covidwho-1146562
9.
Eyes on New Product Development.
Novack, Gary D.
J Ocul Pharmacol Ther ; 36(4): 199-200, 2020 05.
Article in English | MEDLINE | ID: covidwho-9612

Subject(s)
Dry Eye Syndromes/drug therapy , Eye Diseases/drug therapy , Retinal Diseases/drug therapy , Administration, Ophthalmic , Biological Products/therapeutic use , COVID-19/complications , COVID-19/diagnosis , COVID-19/epidemiology , Cell- and Tissue-Based Therapy/methods , Clinical Trials as Topic , Drug Approval/legislation & jurisprudence , Drug Delivery Systems , Drug Design , Genetic Therapy/methods , Humans , SARS-CoV-2/isolation & purification , Safety
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL